An Integrated Research-Clinical BSL-2 Platform for a Live SARS-CoV-2 Neutralization Assay.
Autorzy:
Zou J; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA. Kurhade C; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. Chang HC; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. Hu Y; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA. Meza JA; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. Beaver D; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA. Trinh K; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA. Omlid J; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. Elghetany B; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. Desai R; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. McCaffrey P; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. Garcia JD; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. ShiPY; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA. Ren P; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA. Xie X; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Sealy Institute for Drug Discovery, University of Texas Medical Branch, Galveston, TX 77555, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2023 Aug 31; Vol. 15 (9). Date of Electronic Publication: 2023 Aug 31.
Immunogenicity and Safety of a Third COVID-19 BNT162b2 mRNA Vaccine Dose in 5- to 11-Year Olds.
Autorzy:
Simões EAF; Children's Hospital Colorado and University of Colorado School of Medicine, Aurora, CO, USA. Klein NP; Kaiser Permanente Vaccine Study Center, Kaiser Permanente Northern California, Oakland, CA, USA. Sabharwal C; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA. Gurtman A; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA. Kitchin N; Vaccine Research and Development, Pfizer Ltd, Hurley, UK. Ukkonen B; Espoo Vaccine Research Clinic, Tampere University, Espoo, Finland. Korbal P; Ośrodek Badań Klinicznych In-Vivo, Bydgoszcz-Toruń, Poland. Zou J; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. Xie X; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. Sarwar UN; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA. Xu X; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA. Lockhart S; Vaccine Research and Development, Pfizer Ltd, Hurley, UK. Cunliffe L; Vaccine Research and Development, Pfizer Ltd, Hurley, UK. Lu C; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA. Ma H; Vaccine Research and Development, Pfizer Inc, Collegeville, PA, USA. Swanson KA; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA. Koury K; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA. ShiPY; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. Cooper D; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA. Türeci Ӧ; BioNTech, Mainz, Germany. Jansen KU; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA. Şahin U; BioNTech, Mainz, Germany. Gruber WC; Vaccine Research and Development, Pfizer Inc, Pearl River, NY, USA.
Cable J; PhD Science Writer, New York, New York, USA. Denison MR; Department of Pediatrics and Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center; and Vanderbilt Institute for Infection, Immunology, and Inflammation, Nashville, Tennessee, USA. Kielian M; Department of Cell Biology, Albert Einstein College of Medicine, New York, New York, USA. Jackson WT; Department of Microbiology and Immunology and Center for Pathogen Research, University of Maryland School of Medicine, Baltimore, Maryland, USA. Bartenschlager R; Department of Infectious Diseases, Molecular Virology, Heidelberg University and German Cancer Research Center (DKFZ), Research Division Virus-associated Carcinogenesis, Heidelberg, Germany. Ahola T; Department of Microbiology, Faculty of Agriculture and Forestry, University of Helsinki, Helsinki, Finland. Mukhopadhyay S; Department of Biology, Indiana University, Bloomington, Indiana, USA. Fremont DH; Department of Pathology & Immunology; Department of Molecular Microbiology; and Department of Biochemistry & Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri, USA. Kuhn RJ; Department of Biological Sciences, Purdue University, West Lafayette, Indiana, USA. Shannon A; Architecture et Fonction des Macromolécules Biologiques, CNRS and Aix Marseille Université, Marseille, France. Frazier MN; Signal Transduction Laboratory, National Institute of Environmental Health Sciences, National Institutes of Health, Department of Health and Human Services, Research Triangle Park, North Carolina, USA. Yuen KY; Department of Microbiology, Li Ka Shing Faculty of Medicine and State Key Laboratory of Emerging Infectious Diseases, The University of Hong Kong, Hong Kong, People's Republic of China.; Centre for Virology, Vaccinology and Therapeutics, Hong Kong Science and Technology Park, Hong Kong, People's Republic of China. Coyne CB; Department of Molecular Genetics and Microbiology, Duke University, Durham, North Carolina, USA. Wolthers KC; Department of Medical Microbiology, Amsterdam UMC, University of Amsterdam and Amsterdam Institute for Infection and Immunity, OrganoVIR Labs, Amsterdam, The Netherlands. Ming GL; Department of Neuroscience and Mahoney Institute for Neurosciences, Institute for Regenerative Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Guenther CS; Colorado State University, Fort Collins, Colorado, USA. Moshiri J; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, California, USA. Best SM; Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA. Schoggins JW; Department of Microbiology, University of Texas Southwestern Medical Center, Dallas, Texas, USA. Jurado KA; Department of Microbiology, University of Pennsylvania, Philadelphia, Pennsylvania, USA. Ebel GD; Center for Vector-borne Infectious Diseases, Department of Microbiology, Immunology and Pathology, Colorado State University, Fort Collins, Colorado, USA. Schäfer A; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Ng LFP; ASTAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science Technology and Research (A*STAR), Singapore City, Singapore.; National Institute of Health Research, Health Protection Research Unit in Emerging and Zoonotic Infections; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK. Kikkert M; Department of Medical Microbiology, Leiden University Medical Center, Leiden, The Netherlands. Sette A; Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, California, USA.; Division of Infectious Diseases and Global Public Health, Department of Medicine, University of California, San Diego, La Jolla, California, USA. Harris E; Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, California, USA. Wing PAC; Nuffield Department of Medicine and Chinese Academy of Medical Sciences Oxford Institute, University of Oxford, Oxford, UK. Eggenberger J; Department of Immunology, University of Washington School of Medicine, Seattle, Washington, USA. Krishnamurthy SR; Metaorganism Immunity Section, Laboratory of Immune System Biology and NIAID Microbiome Program, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA. Mah MG; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore City, Singapore. Meganck RM; Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA. Chung D; Department of Experimental Therapeutics, MD Anderson Cancer Center, Houston, Texas, USA. Maurer-Stroh S; Yong Loo Lin School of Medicine and Department of Biological Sciences, National University of Singapore, Singapore City, Singapore.; Bioinformatics Institute, Agency for Science, Technology and Research, Singapore City, Singapore. Andino R; Department of Microbiology and Immunology, University of California, San Francisco, San Francisco, California, USA. Korber B; Los Alamos National Laboratory, Los Alamos, New Mexico, USA. Perlman S; Department of Microbiology and Immunology, and Department of Pediatrics, University of Iowa, Iowa City, Iowa, USA. ShiPY; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, USA. Bárcena M; Section Electron Microscopy, Department of Cell and Chemical Biology, Leiden University Medical Center, Leiden, The Netherlands. Aicher SM; Institut Pasteurgrid, Université de Paris Cité, Virus Sensing and Signaling Unit, Paris, France. Vu MN; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, USA. Kenney DJ; Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, Massachusetts, USA. Lindenbach BD; Department of Microbial Pathogenesis, Yale University School of Medicine, New Haven, Connecticut, USA. Nishida Y; Chugai Pharmaceutical, Co., Tokyo, Japan.; Lee Kong Chian School of Medicine and School of Biological Sciences, Nanyang Technological University, Singapore City, Singapore. Rénia L; ASTAR Infectious Diseases Labs (A*STAR ID Labs), Agency for Science Technology and Research (A*STAR), Singapore City, Singapore. Williams EP; Department of Microbiology, Immunology, and Biochemistry, The University of Tennessee Health Science Center, Memphis, Tennessee, USA.
Journal Article; Research Support, U.S. Gov't, P.H.S.; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Intramural; Research Support, N.I.H., Extramural
Expanded profiling of Remdesivir as a broad-spectrum antiviral and low potential for interaction with other medications in vitro.
Autorzy:
Radoshitzky SR; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA.; Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA. Iversen P; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA. Lu X; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Zou J; Department of Biochemistry & Molecular Biology, Institute for Drug Discovery, Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA. Kaptein SJF; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, B-3000, Leuven, Belgium.; Global Virus Network, GVN, Baltimore, USA. Stuthman KS; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA. Van Tongeren SA; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA. Steffens J; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA. Gong R; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Truong H; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Sapre AA; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Yang H; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Xie X; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Chia JJ; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Song ZJ; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Leventhal SM; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Chan J; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Shornikov A; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Zhang X; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, B-3000, Leuven, Belgium.; Global Virus Network, GVN, Baltimore, USA. Cowfer D; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Yu H; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Warren T; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA.; Laulima Government Solutions, LLC., Orlando, FL, USA. Cihlar T; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Porter DP; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Neyts J; KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, B-3000, Leuven, Belgium.; Global Virus Network, GVN, Baltimore, USA. ShiPY; Department of Biochemistry & Molecular Biology, Institute for Drug Discovery, Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX, USA. Wells J; The Geneva Foundation, United States Army Medical Research Institute of Infectious Diseases (USAMRIID), Fort Detrick, Frederick, MD, USA. Bilello JP; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. Feng JY; Gilead Sciences, Inc, 333 Lakeside Drive, Foster City, CA, USA. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2023 Feb 23; Vol. 13 (1), pp. 3131. Date of Electronic Publication: 2023 Feb 23.
The human disease gene LYSET is essential for lysosomal enzyme transport and viral infection.
Autorzy:
Richards CM; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA. Jabs S; Institute of Clinical Molecular Biology, Christian-Albrechts-University and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany. Qiao W; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA. Varanese LD; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA. Schweizer M; Department of Electron Microscopy, Center for Molecular Neurobiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Mosen PR; Institute for Biochemistry and Molecular Biology, Medical Faculty, Rheinische Friedrich-Wilhelms-University of Bonn, Bonn, Germany. Riley NM; Department of Chemistry, Stanford University, Stanford, CA, USA. Klüssendorf M; Department of Osteology and Biomechanics, Cell Biology of Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Zengel JR; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA. Flynn RA; Stem Cell Program, Boston Children's Hospital, Boston, MA, USA.; Stem Cell and Regenerative Biology Department, Harvard University, Cambridge, MA, USA. Rustagi A; Division of Infectious Disease and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. Widen JC; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. Peters CE; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA. Ooi YS; Programme in Emerging Infectious Diseases, Duke-NUS Medical School, Singapore, Singapore. Xie X; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. ShiPY; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, TX, USA. Bartenschlager R; Department of Infectious Diseases, Molecular Virology, Heidelberg University, Heidelberg, Germany.; Division Virus-Associated Carcinogenesis, German Cancer Research Center (DKFZ), Heidelberg, Germany. Puschnik AS; Chan Zuckerberg Biohub, San Francisco, CA, USA. Bogyo M; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA. Bertozzi CR; Department of Chemistry, Stanford University, Stanford, CA, USA.; Howard Hughes Medical Institute, Stanford, CA, USA. Blish CA; Division of Infectious Disease and Geographic Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA. Winter D; Institute for Biochemistry and Molecular Biology, Medical Faculty, Rheinische Friedrich-Wilhelms-University of Bonn, Bonn, Germany. Nagamine CM; Department of Comparative Medicine, Stanford University School of Medicine, Stanford, CA, USA. Braulke T; Department of Osteology and Biomechanics, Cell Biology of Rare Diseases, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. Carette JE; Department of Microbiology and Immunology, Stanford University School of Medicine, Stanford, CA, USA.
Pokaż więcej
Źródło:
Science (New York, N.Y.) [Science] 2022 Oct 07; Vol. 378 (6615), pp. eabn5648. Date of Electronic Publication: 2022 Oct 07.
Nucleocapsid mutations in SARS-CoV-2 augment replication and pathogenesis.
Autorzy:
Johnson BA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America. Zhou Y; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States of America. Lokugamage KG; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America. Vu MN; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America. Bopp N; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America. Crocquet-Valdes PA; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America. Kalveram B; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America. Schindewolf C; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America. Liu Y; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States of America. Scharton D; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.; World Reference Center of Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, Texas, United States of America. Plante JA; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.; World Reference Center of Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, Texas, United States of America. Xie X; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States of America. Aguilar P; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.; Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America. Weaver SC; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.; World Reference Center of Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, Texas, United States of America.; Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America.; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, Texas, United States of America. ShiPY; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States of America.; World Reference Center of Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, Texas, United States of America.; Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America.; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, Texas, United States of America.; Institute for Drug Discovery, University of Texas Medical Branch, Galveston, Texas, United States of America. Walker DH; Department of Pathology, University of Texas Medical Branch, Galveston, Texas, United States of America.; Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America. Routh AL; Department of Biochemistry and Molecular Biology, University of Texas Medical Branch, Galveston, Texas, United States of America.; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, Texas, United States of America. Plante KS; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.; World Reference Center of Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, Texas, United States of America. Menachery VD; Department of Microbiology and Immunology, University of Texas Medical Branch, Galveston, Texas, United States of America.; World Reference Center of Emerging Viruses and Arboviruses, University of Texas Medical Branch, Galveston, Texas, United States of America.; Center for Biodefense and Emerging Infectious Diseases, University of Texas Medical Branch, Galveston, Texas, United States of America.
Pokaż więcej
Źródło:
PLoS pathogens [PLoS Pathog] 2022 Jun 21; Vol. 18 (6), pp. e1010627. Date of Electronic Publication: 2022 Jun 21 (Print Publication: 2022).
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, P.H.S.
A Single-Round Infection Fluorescent SARS-CoV-2 Neutralization Test for COVID-19 Serological Testing at a Biosafety Level-2 Laboratory.
Autorzy:
Zou J; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA. Xia H; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA. ShiPY; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA.; Sealy Institute for Drug Discovery, University of Texas Medical Branch, Galveston, TX 77555, USA.; Institute for Translational Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA.; Sealy Institute for Vaccine Sciences, University of Texas Medical Branch, Galveston, TX 77555, USA.; Sealy Center for Structural Biology & Molecular Biophysics, University of Texas Medical Branch, Galveston, TX 77555, USA. Xie X; Department of Biochemistry & Molecular Biology, University of Texas Medical Branch, Galveston, TX 77555, USA.; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA. Ren P; Institute for Human Infection and Immunity, University of Texas Medical Branch, Galveston, TX 77555, USA.; Department of Pathology, University of Texas Medical Branch, Galveston, TX 77555, USA.
Pokaż więcej
Źródło:
Viruses [Viruses] 2022 Jun 02; Vol. 14 (6). Date of Electronic Publication: 2022 Jun 02.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
A platform of assays for the discovery of anti-Zika small-molecules with activity in a 3D-bioprinted outer-blood-retina model.
Autorzy:
Dorjsuren D; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America. Eastman RT; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America. Song MJ; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America. Yasgar A; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America. Chen Y; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America. Bharti K; Unit on Ocular and Stem Cell Translational Research, National Eye Institute, National Institutes of Health, Bethesda, Maryland, United States of America. Zakharov AV; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America. Jadhav A; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America. Ferrer M; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America. ShiPY; University of Texas Medical Branch Galveston, Galveston, TX, United States of America. Simeonov A; Division of Preclinical Innovation, National Center for Advancing Translational Sciences, National Institutes of Health, Rockville, Maryland, United States of America.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2022 Jan 18; Vol. 17 (1), pp. e0261821. Date of Electronic Publication: 2022 Jan 18 (Print Publication: 2022).
Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies
